Gene: Vim (vimentin)  Mus musculus Symbol: Vim Name: vimentin Description: ENCODES a protein that exhibits structural constituent of eye lens; structural molecule activity; identical protein binding (ortholog); INVOLVED IN astrocyte development; Bergmann glial cell differentiation; intermediate filament organization; ASSOCIATED WITH abnormal angiogenesis; abnormal astrocyte morphology; abnormal astrocyte physiology; ASSOCIATED WITH Alzheimer Disease; Brain Injuries; Head Injuries, Penetrating; FOUND IN cell leading edge; cell projection; cytoplasm; INTERACTS WITH 17alpha-ethynylestradiol; 2,3,7,8-tetrachlorodibenzodioxine; 3',5'-cyclic GMP Type: protein-coding RefSeq Status: PROVISIONAL Also known as: MGC102095; OTTMUSP00000012058; vimentin Orthologs: Homo sapiens : VIM (vimentin)  HGNC Rattus norvegicus : Vim (vimentin) Latest Assembly: Mouse Genome Assembly Build 37 Position: Map Chr Position Strand Source Mouse Genome Assembly GRCm38 2 13,574,311 - 13,582,826 + NCBI Mouse cM Map 2 10.04   NCBI Mouse Celera Assembly 2 13,484,803 - 13,493,320 + NCBI Mouse Genome Assembly Build 37 2 13,495,938 - 13,504,453 + NCBI Mouse Genome Assembly Build 36.1 2 13,495,579 - 13,504,434 + NCBI Mouse Cytogenetic Map 2 A2   NCBI Model Launch Genome Browser (GBrowse) Annotation    (Toggle Detail/Summary View) Disease Annotations Term Qualifier Evidence With Reference Notes Source Original Reference(s) Alzheimer Disease   IEP   6480519 protein:increased expression:brain RGD   Alzheimer Disease   ISS RGD:733128 6480519 protein:increased expression:brain RGD   Arthritis, Experimental   ISS RGD:621646 6480480   RGD   Arthritis, Rheumatoid   ISS RGD:733128 6480508   RGD   Atherosclerosis   ISS RGD:733128 6480618 associated with arthritis,rheumatoid RGD   Behcet Syndrome   ISS RGD:733128 6480476   RGD   Brain Infarction   ISS RGD:621646 6480443   RGD   Brain Injuries   ISS RGD:621646 6480527   RGD   Brain Injuries   IEP   6480519 protein:increased expression:brain RGD   Cataract   ISS RGD:733128 7240710   OMIM   Chagas Disease   ISS RGD:621646 6480538 protein:increased expression:plasma RGD   Chagas Disease Severity ISS RGD:733128 6480538 protein:increased expression:plasma RGD   Coronary Artery Disease   ISS RGD:733128 6480617 protein:increased expression:monocyte RGD   Fever   ISS RGD:621646 1304397 protein:increased expression:glial cell RGD   Gliosis   ISS RGD:621646 6480626 associated with head injuries, penetrating RGD   Gliosis   ISS RGD:621646 6480622 associated with alcohol-induced disorders, nervous system;protein:increased expression:astrocyte RGD   Head Injuries, Closed   ISS RGD:621646 6480531   RGD   Head Injuries, Penetrating   IPM   6480471   RGD   Hyperthyroidism   ISS RGD:621646 6480446 protein:increased expression, hyperphosphorylation:testis RGD   Liver Neoplasms, Experimental   ISS RGD:621646 6480440   RGD   Lupus Erythematosus, Systemic   ISS RGD:733128 6480476   RGD   Nephrosis   ISS RGD:621646 6480447 mRNA,protein:increased expression:podocyte RGD   Sjogren's Syndrome   ISS RGD:733128 6480477   RGD   Spinal Cord Injuries   IPM   6480471   RGD   Spinal Cord Injuries   ISS RGD:621646 6480511 protein:increased expression:spinal cord RGD   Urination Disorders   ISS RGD:621646 6480511 associated with spinal cord injuries RGD   Gene-Chemical Interaction Annotations Term Qualifier Evidence With Reference Notes Source Original Reference(s) (3S,5R)-fluvastatin multiple interactions ISO RGD:621646 6480464 fluvastatin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of VIM mRNA] CTD PMID:16452496 (S)-nicotine decreases expression ISO RGD:733128 6480464 Nicotine results in decreased expression of VIM mRNA CTD PMID:18247414 (S)-nicotine increases expression ISO RGD:733128 6480464 Nicotine results in increased expression of VIM mRNA CTD PMID:23219715 (S)-nicotine increases expression ISO RGD:733128 6480464 Nicotine results in increased expression of VIM protein CTD PMID:18844224 1,3-dinitrobenzene increases metabolic processing ISO RGD:621646 6480464 3-dinitrobenzene results in increased metabolism of VIM protein CTD PMID:21402099 17alpha-ethynylestradiol multiple interactions EXP   6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of VIM mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP   6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of VIM mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733128 6480464 Tetrachlorodibenzodioxin results in increased expression of VIM mRNA; more ... CTD PMID:22902829 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:621646 6480464 Tetrachlorodibenzodioxin results in increased expression of VIM mRNA CTD PMID:20959002 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:621646 6480464 Tetrachlorodibenzodioxin results in decreased expression of VIM mRNA CTD PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP   6480464 Tetrachlorodibenzodioxin affects the expression of VIM mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:621646 6480464 Tetrachlorodibenzodioxin affects the expression of VIM mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP   6480464 Tetrachlorodibenzodioxin results in increased expression of VIM mRNA CTD PMID:21041162 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:621646 6480464 Tetrachlorodibenzodioxin results in decreased expression of VIM protein CTD PMID:16548065 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:621646 6480464 Tetrachlorodibenzodioxin results in increased expression of VIM protein CTD PMID:19201780 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP   6480464 Tetrachlorodibenzodioxin results in decreased expression of VIM mRNA CTD PMID:20159946 2-naphthylamine decreases expression ISO RGD:733128 6480464 2-Naphthylamine results in decreased expression of VIM mRNA CTD PMID:18247414 2-nitrofluorene increases expression ISO RGD:621646 6480464 2-nitrofluorene results in increased expression of VIM mRNA CTD PMID:14600272 3',5'-cyclic GMP multiple interactions EXP   6480464 VIM protein affects the susceptibility to [Acetylcholine co-treated with Cyclic GMP co-treated with Indomethacin] CTD PMID:11588525 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine multiple interactions ISO RGD:621646 6480464 fluvastatin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of VIM mRNA] CTD PMID:16452496 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression ISO RGD:621646 6480464 Puromycin Aminonucleoside results in increased expression of VIM mRNA CTD PMID:16452496 3H-1,2-dithiole-3-thione decreases expression ISO RGD:621646 6480464 1,2-dithiol-3-thione results in decreased expression of VIM mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP   6480464 4,4'-diaminodiphenylmethane results in increased expression of VIM mRNA CTD PMID:18648102 4,4'-diaminodiphenylmethane decreases expression ISO RGD:621646 6480464 4,4'-diaminodiphenylmethane results in decreased expression of VIM mRNA CTD PMID:18289764 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression ISO RGD:621646 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of VIM mRNA CTD PMID:14600272 4-hydroperoxycyclophosphamide decreases expression EXP   6480464 perfosfamide results in decreased expression of VIM mRNA CTD PMID:19429390 4-hydroxynon-2-enal affects binding ISO RGD:733128 6480464 VIM protein binds to 4-hydroxy-2-nonenal CTD PMID:20043646 4-hydroxyphenyl retinamide multiple interactions ISO RGD:733128 6480464 Cholecalciferol promotes the reaction [Fenretinide results in decreased expression of VIM] CTD PMID:17024972 4-hydroxyphenyl retinamide decreases expression ISO RGD:733128 6480464 Fenretinide results in decreased expression of VIM CTD PMID:17024972 5-aza-2'-deoxycytidine increases expression ISO RGD:733128 6480464 decitabine results in increased expression of VIM mRNA CTD PMID:19194470 5-aza-2'-deoxycytidine increases expression ISO RGD:733128 6480464 decitabine results in increased expression of VIM protein CTD PMID:18025290 5-azacytidine decreases expression ISO RGD:621646 6480464 Azacitidine results in decreased expression of VIM protein CTD PMID:17105402 6-propyl-2-thiouracil increases expression ISO RGD:621646 6480464 Propylthiouracil results in increased expression of VIM mRNA; more ... CTD PMID:22504374 acetylcholine multiple interactions EXP   6480464 VIM protein affects the susceptibility to [Acetylcholine co-treated with Cyclic GMP co-treated with Indomethacin]; more ... CTD PMID:11588525 acrolein increases metabolic processing ISO RGD:733128 6480464 Acrolein results in increased metabolism of VIM protein CTD PMID:20015449 aflatoxin B1 decreases expression EXP   6480464 Aflatoxin B1 results in decreased expression of VIM mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:733128 6480464 Tretinoin results in decreased expression of VIM mRNA CTD PMID:17045167 more ... all-trans-retinoic acid decreases expression ISO RGD:733128 6480464 Tretinoin results in decreased expression of VIM mRNA CTD PMID:15498508 more ... all-trans-retinoic acid decreases expression ISO RGD:733128 6480464 Tretinoin results in decreased expression of VIM mRNA CTD PMID:17045167 more ... all-trans-retinoic acid decreases expression ISO RGD:733128 6480464 Tretinoin results in decreased expression of VIM mRNA CTD PMID:15498508 more ... all-trans-retinoic acid decreases expression ISO RGD:733128 6480464 Tretinoin results in decreased expression of VIM mRNA CTD PMID:15498508 more ... all-trans-retinoic acid decreases expression ISO RGD:733128 6480464 Tretinoin results in decreased expression of VIM mRNA CTD PMID:17218384 more ... all-trans-retinoic acid decreases expression ISO RGD:733128 6480464 Tretinoin results in decreased expression of VIM mRNA CTD PMID:17045167 more ... all-trans-retinoic acid decreases expression EXP   6480464 Tretinoin results in decreased expression of VIM mRNA CTD PMID:16604517 ammonium chloride affects expression ISO RGD:621646 6480464 Ammonium Chloride affects the expression of VIM mRNA CTD PMID:16483693 andrographolide multiple interactions EXP   6480464 [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of VIM mRNA CTD PMID:19737545 arsenite(3-) increases oxidation ISO RGD:733128 6480464 arsenite results in increased oxidation of VIM protein CTD PMID:20196163 arsenite(3-) increases expression ISO RGD:621646 6480464 arsenite results in increased expression of VIM protein CTD PMID:21344382 bacitracin increases expression ISO RGD:621646 6480464 Bacitracin results in increased expression of VIM mRNA CTD PMID:18289764 bathocuproine disulfonic acid multiple interactions ISO RGD:733128 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of VIM mRNA] CTD PMID:15477007 benzo[a]pyrene decreases expression ISO RGD:733128 6480464 Benzo(a)pyrene results in decreased expression of VIM mRNA CTD PMID:18247414 benzo[a]pyrene increases expression EXP   6480464 Benzo(a)pyrene results in increased expression of VIM mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression EXP   6480464 Benzo(a)pyrene results in decreased expression of VIM mRNA CTD PMID:19770486 bis(2-ethylhexyl) phthalate multiple interactions EXP   6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of VIM mRNA] CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:621646 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of VIM promoter CTD PMID:23359474 bis(2-ethylhexyl) phthalate increases expression ISO RGD:621646 6480464 Diethylhexyl Phthalate results in increased expression of VIM protein CTD PMID:20420898 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:621646 6480464 Diethylhexyl Phthalate results in decreased expression of VIM mRNA CTD PMID:20920545 bis(2-ethylhexyl) phthalate increases expression EXP   6480464 Diethylhexyl Phthalate results in increased expression of VIM mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:621646 6480464 Diethylhexyl Phthalate results in decreased expression of VIM protein CTD PMID:19344669 bisphenol A decreases expression ISO RGD:733128 6480464 bisphenol A results in decreased expression of VIM mRNA CTD PMID:22576693 bisphenol A multiple interactions ISO RGD:621646 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of VIM promoter CTD PMID:23359474 cadmium atom decreases expression ISO RGD:733128 6480464 Cadmium results in decreased expression of VIM mRNA CTD PMID:16439709 cadmium dichloride multiple interactions ISO RGD:733128 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of VIM mRNA CTD PMID:12634122 cadmium dichloride multiple interactions ISO RGD:733128 6480464 HSPB3 inhibits the reaction [Cadmium Chloride results in increased metabolism of VIM protein] CTD PMID:16264267 cadmium dichloride increases metabolic processing ISO RGD:733128 6480464 Cadmium Chloride results in increased metabolism of VIM protein CTD PMID:16264267 cadmium dichloride decreases expression ISO RGD:621646 6480464 Cadmium Chloride results in decreased expression of VIM mRNA CTD PMID:18636176 calciol multiple interactions ISO RGD:733128 6480464 Cholecalciferol promotes the reaction [Fenretinide results in decreased expression of VIM] CTD PMID:17024972 calciol decreases expression ISO RGD:733128 6480464 Cholecalciferol results in decreased expression of VIM CTD PMID:17024972 calcitriol increases expression ISO RGD:733128 6480464 Calcitriol results in increased expression of VIM mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:733128 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of VIM mRNA CTD PMID:21592394 calcitriol decreases expression ISO RGD:733128 6480464 Calcitriol results in decreased expression of VIM mRNA CTD PMID:16129123 calcium atom multiple interactions ISO RGD:621646 6480464 Calcium affects the reaction [diphenylditelluride results in increased phosphorylation of VIM protein] CTD PMID:21879721 calcium(0) multiple interactions ISO RGD:621646 6480464 Calcium affects the reaction [diphenylditelluride results in increased phosphorylation of VIM protein] CTD PMID:21879721 capsaicin multiple interactions ISO RGD:621646 6480464 Capsaicin inhibits the reaction [Dietary Fats results in increased expression of VIM protein] CTD PMID:20359164 carboplatin decreases expression ISO RGD:621646 6480464 Carboplatin results in decreased expression of VIM mRNA CTD PMID:18172885 carvedilol multiple interactions ISO RGD:621646 6480464 carvedilol inhibits the reaction [Streptozocin results in increased expression of VIM protein] CTD PMID:12140129 choline multiple interactions EXP   6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of VIM mRNA CTD PMID:20938992 cis-ketoconazole affects expression ISO RGD:621646 6480464 Ketoconazole affects the expression of VIM mRNA CTD PMID:18289764 cisplatin decreases expression ISO RGD:733128 6480464 Cisplatin results in decreased expression of VIM protein CTD PMID:21924258 cisplatin decreases expression ISO RGD:621646 6480464 Cisplatin results in decreased expression of VIM mRNA CTD PMID:22023808 PMID:18172885 cisplatin increases expression ISO RGD:621646 6480464 Cisplatin results in increased expression of VIM protein CTD PMID:15033597 PMID:16837816 cisplatin multiple interactions ISO RGD:621646 6480464 Selenium inhibits the reaction [Cisplatin results in increased expression of VIM protein] CTD PMID:16837816 cisplatin increases expression ISO RGD:621646 6480464 Cisplatin results in increased expression of VIM protein CTD PMID:16837816 PMID:15033597 cisplatin increases expression ISO RGD:621646 6480464 Cisplatin results in increased expression of VIM mRNA CTD PMID:18289764 cisplatin decreases expression ISO RGD:621646 6480464 Cisplatin results in decreased expression of VIM mRNA CTD PMID:18172885 PMID:22023808 cisplatin multiple interactions ISO RGD:733128 6480464 U 0126 inhibits the reaction [Cisplatin results in increased expression of VIM mRNA] CTD PMID:21618587 cisplatin increases expression ISO RGD:733128 6480464 Cisplatin results in increased expression of VIM mRNA; more ... CTD PMID:21618587 clofibrate increases expression ISO RGD:621646 6480464 Clofibrate results in increased expression of VIM protein CTD PMID:16470657 clofibric acid affects expression ISO RGD:621646 6480464 Clofibric Acid affects the expression of VIM mRNA CTD PMID:17602206 cobalt dichloride increases expression ISO RGD:733128 6480464 cobaltous chloride results in increased expression of VIM mRNA CTD PMID:19376846 cobalt dichloride decreases expression ISO RGD:621646 6480464 cobaltous chloride results in decreased expression of VIM protein CTD PMID:12819242 copper atom multiple interactions EXP   6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of VIM mRNA CTD PMID:15467011 copper atom decreases expression ISO RGD:733128 6480464 Copper results in decreased expression of VIM protein CTD PMID:22692975 copper atom affects binding ISO RGD:733128 6480464 VIM protein binds to Copper CTD PMID:14534351 copper(0) multiple interactions EXP   6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of VIM mRNA CTD PMID:15467011 copper(0) decreases expression ISO RGD:733128 6480464 Copper results in decreased expression of VIM protein CTD PMID:22692975 copper(0) affects binding ISO RGD:733128 6480464 VIM protein binds to Copper CTD PMID:14534351 cyclophosphamide affects expression ISO RGD:621646 6480464 Cyclophosphamide affects the expression of VIM mRNA CTD PMID:10859244 cyclosporin A increases expression EXP   6480464 Cyclosporine results in increased expression of VIM protein CTD PMID:22416070 cypermethrin increases expression EXP   6480464 cypermethrin results in increased expression of VIM mRNA CTD PMID:21142847 D-glucose increases expression ISO RGD:733128 6480464 Glucose results in increased expression of VIM mRNA; more ... CTD PMID:21829520 D-glucose multiple interactions ISO RGD:733128 6480464 [Glucose co-treated with TGFB1 protein] results in increased expression of VIM protein; more ... CTD PMID:21829520 dantrolene multiple interactions ISO RGD:621646 6480464 Dantrolene inhibits the reaction [diphenylditelluride results in increased phosphorylation of VIM protein] CTD PMID:21879721 dantrolene multiple interactions ISO RGD:621646 6480464 Dantrolene inhibits the reaction [diphenylditelluride results in decreased phosphorylation of VIM protein] CTD PMID:21863293 daunorubicin increases expression ISO RGD:621646 6480464 Daunorubicin results in increased expression of VIM protein CTD PMID:2444108 DDT increases expression ISO RGD:733128 6480464 DDT results in increased expression of VIM mRNA; more ... CTD PMID:22902829 Delta(9)-tetrahydrocannabinol multiple interactions ISO RGD:621646 6480464 [Tetrahydrocannabinol co-treated with Ethanol] results in decreased expression of VIM mRNA CTD PMID:17618662 Delta(9)-tetrahydrocannabinol decreases expression ISO RGD:621646 6480464 Tetrahydrocannabinol results in decreased expression of VIM mRNA CTD PMID:17618662 dexamethasone increases expression EXP   6480464 Dexamethasone results in increased expression of VIM mRNA CTD PMID:21041162 diazoxide decreases expression EXP   6480464 Isoproterenol results in decreased expression of VIM mRNA CTD PMID:21335049 dibutyl phthalate increases expression EXP   6480464 Dibutyl Phthalate results in increased expression of VIM mRNA CTD PMID:21266533 dibutyl phthalate multiple interactions ISO RGD:621646 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of VIM promoter CTD PMID:23359474 dibutyl phthalate increases expression ISO RGD:733128 6480464 Dibutyl Phthalate results in increased expression of VIM protein CTD PMID:22552774 dibutyl phthalate multiple interactions ISO RGD:733128 6480464 Dibutyl Phthalate promotes the reaction [[TCF4 protein binds to LEF1 protein] which binds to VIM protein]; more ... CTD PMID:22552774 dibutyl phthalate decreases expression ISO RGD:621646 6480464 Dibutyl Phthalate results in decreased expression of VIM mRNA CTD PMID:17379624 dichromium trioxide multiple interactions ISO RGD:733128 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of VIM mRNA CTD PMID:12634122 diclofenac decreases expression ISO RGD:733128 6480464 Diclofenac results in decreased expression of VIM protein CTD PMID:19628293 diethylstilbestrol increases expression EXP   6480464 Diethylstilbestrol results in increased expression of VIM mRNA CTD PMID:21041162 disodium selenite increases expression ISO RGD:733128 6480464 Sodium Selenite results in increased expression of VIM mRNA CTD PMID:18175754 doxorubicin decreases expression EXP   6480464 Doxorubicin results in decreased expression of VIM mRNA CTD PMID:16243910 doxorubicin increases expression EXP   6480464 Doxorubicin results in increased expression of VIM mRNA CTD PMID:22016648 doxorubicin multiple interactions ISO RGD:621646 6480464 Sodium Bicarbonate inhibits the reaction [Doxorubicin results in increased expression of VIM protein] CTD PMID:10430982 doxorubicin increases expression ISO RGD:621646 6480464 Doxorubicin results in increased expression of VIM protein CTD PMID:10430982 doxorubicin increases expression EXP   6480464 Doxorubicin results in increased expression of VIM protein CTD PMID:16144979 doxorubicin multiple interactions EXP   6480464 [Doxorubicin co-treated with MT2A protein] results in decreased expression of VIM protein CTD PMID:16144979 elemental selenium increases expression ISO RGD:733128 6480464 Selenium results in increased expression of VIM mRNA CTD PMID:19244175 elemental selenium increases expression ISO RGD:621646 6480464 Selenium deficiency results in increased expression of VIM protein CTD PMID:17109141 elemental selenium multiple interactions ISO RGD:621646 6480464 Selenium inhibits the reaction [Cisplatin results in increased expression of VIM protein] CTD PMID:16837816 endosulfan increases expression ISO RGD:733128 6480464 Endosulfan results in increased expression of VIM protein CTD PMID:22677888 endosulfan increases expression ISO RGD:733128 6480464 Endosulfan results in increased expression of VIM protein CTD PMID:22677888 PMID:22902829 endosulfan increases expression ISO RGD:733128 6480464 Endosulfan results in increased expression of VIM mRNA CTD PMID:22902829 ethanol decreases expression ISO RGD:621646 6480464 Ethanol results in decreased expression of VIM mRNA CTD PMID:17618662 ethanol multiple interactions ISO RGD:621646 6480464 [Tetrahydrocannabinol co-treated with Ethanol] results in decreased expression of VIM mRNA CTD PMID:17618662 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions ISO RGD:621646 6480464 [1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [diphenylditelluride results in increased phosphorylation of VIM protein] CTD PMID:21879721 folic acid multiple interactions EXP   6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of VIM mRNA CTD PMID:20938992 glucose increases expression ISO RGD:733128 6480464 Glucose results in increased expression of VIM mRNA; more ... CTD PMID:21829520 glucose multiple interactions ISO RGD:733128 6480464 [Glucose co-treated with TGFB1 protein] results in increased expression of VIM protein; more ... CTD PMID:21829520 heptachlor increases expression ISO RGD:733128 6480464 Heptachlor results in increased expression of VIM protein; more ... CTD PMID:22902829 heptadecafluorononanoic acid increases expression ISO RGD:621646 6480464 perfluoro-n-nonanoic acid results in increased expression of VIM mRNA CTD PMID:20580666 hyaluronic acid increases expression EXP   6480464 Hyaluronic Acid analog results in increased expression of VIM protein CTD PMID:20159036 hyaluronic acid multiple interactions ISO RGD:621646 6480464 Hyaluronic Acid analog affects the reaction [Hydrogen Peroxide affects the expression of VIM protein] CTD PMID:23178681 hyaluronic acid affects expression ISO RGD:621646 6480464 Hyaluronic Acid analog affects the expression of VIM protein CTD PMID:23178681 hydrogen peroxide multiple interactions ISO RGD:621646 6480464 Hyaluronic Acid analog affects the reaction [Hydrogen Peroxide affects the expression of VIM protein] CTD PMID:23178681 hydrogen peroxide affects expression ISO RGD:621646 6480464 Hydrogen Peroxide affects the expression of VIM protein CTD PMID:23178681 indole-3-methanol decreases expression ISO RGD:733128 6480464 indole-3-carbinol results in decreased expression of VIM protein CTD PMID:18025290 indomethacin multiple interactions EXP   6480464 VIM protein affects the susceptibility to [Acetylcholine co-treated with Indomethacin]; more ... CTD PMID:11588525 indomethacin increases expression ISO RGD:621646 6480464 Indomethacin results in increased expression of VIM mRNA CTD PMID:18299717 ionomycin multiple interactions ISO RGD:733128 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of VIM mRNA] CTD PMID:15477007 isoprenaline decreases expression EXP   6480464 Isoproterenol results in decreased expression of VIM mRNA CTD PMID:21335049 L-ascorbic acid increases expression EXP   6480464 Ascorbic Acid results in increased expression of VIM mRNA CTD PMID:22139585 L-methionine multiple interactions EXP   6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of VIM mRNA CTD PMID:20938992 lead diacetate multiple interactions ISO RGD:733128 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of VIM mRNA CTD PMID:12634122 lithium chloride increases expression ISO RGD:621646 6480464 Lithium Chloride results in increased expression of VIM protein CTD PMID:8773480 methimazole increases expression ISO RGD:621646 6480464 Methimazole results in increased expression of VIM mRNA; more ... CTD PMID:22504374 microcystin-LR multiple interactions ISO RGD:733128 6480464 SB 203580 inhibits the reaction [cyanoginosin LR results in increased phosphorylation of VIM protein]; more ... CTD PMID:22960429 microcystin-LR increases phosphorylation ISO RGD:733128 6480464 cyanoginosin LR results in increased phosphorylation of VIM protein CTD PMID:22960429 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:621646 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of VIM mRNA CTD PMID:22087261 morphine multiple interactions ISO RGD:621646 6480464 Morphine deficiency affects the reaction [Morphine results in increased expression of VIM protein] CTD PMID:23056601 morphine increases expression ISO RGD:621646 6480464 Morphine results in increased expression of VIM protein CTD PMID:23056601 N(6)-dimethylallyladenine decreases expression ISO RGD:733128 6480464 N(6)-(delta(2)-isopentenyl)adenine results in decreased expression of VIM mRNA CTD PMID:16129123 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO RGD:733128 6480464 Methylnitronitrosoguanidine results in increased expression of VIM mRNA CTD PMID:12773770 PMID:12634122 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO RGD:733128 6480464 Methylnitronitrosoguanidine results in increased expression of VIM mRNA CTD PMID:12634122 PMID:12773770 N-nitrosodiethylamine multiple interactions ISO RGD:621646 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of VIM mRNA CTD PMID:18164116 N-nitrosodiethylamine multiple interactions EXP   6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of VIM mRNA] CTD PMID:17942915 N-nitrosodiethylamine increases expression EXP   6480464 Diethylnitrosamine results in increased expression of VIM mRNA CTD PMID:17942915 N-nitrosodiethylamine increases expression ISO RGD:733128 6480464 Diethylnitrosamine results in increased expression of VIM mRNA CTD PMID:21527772 N-nitrosodiethylamine multiple interactions ISO RGD:621646 6480464 [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of VIM protein CTD PMID:20935162 N-nitrosodiethylamine increases expression ISO RGD:621646 6480464 Diethylnitrosamine results in increased expression of VIM mRNA CTD PMID:19638242 N-nitrosodimethylamine increases expression ISO RGD:621646 6480464 Dimethylnitrosamine results in increased expression of VIM mRNA CTD PMID:14600272 nifedipine multiple interactions ISO RGD:621646 6480464 Nifedipine inhibits the reaction [diphenylditelluride results in decreased phosphorylation of VIM protein] CTD PMID:21863293 ochratoxin A decreases expression EXP   6480464 ochratoxin A results in decreased expression of VIM protein CTD PMID:19445961 ochratoxin A increases expression ISO RGD:621646 6480464 ochratoxin A results in increased expression of VIM mRNA CTD PMID:15994020 PMID:18308701 ochratoxin A increases expression ISO RGD:621646 6480464 ochratoxin A results in increased expression of VIM protein CTD PMID:18308701 oxcarbazepine affects expression ISO RGD:621646 6480464 oxcarbazepine affects the expression of VIM protein CTD PMID:22142741 ozone increases expression ISO RGD:621646 6480464 Ozone results in increased expression of VIM mRNA CTD PMID:16716893 paracetamol affects expression EXP   6480464 Acetaminophen affects the expression of VIM mRNA CTD PMID:17562736 phenethyl isothiocyanate increases metabolic processing ISO RGD:733128 6480464 phenethyl isothiocyanate results in increased metabolism of VIM protein CTD PMID:21838287 phenethyl isothiocyanate affects binding ISO RGD:733128 6480464 VIM protein binds to phenethyl isothiocyanate CTD PMID:21838287 phenobarbital multiple interactions ISO RGD:621646 6480464 [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of VIM protein CTD PMID:20935162 phenobarbital affects expression EXP   6480464 Phenobarbital affects the expression of VIM mRNA CTD PMID:23091169 phenytoin increases expression ISO RGD:733128 6480464 Phenytoin results in increased expression of VIM mRNA CTD PMID:14741686 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:733128 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of VIM mRNA] CTD PMID:15477007 pirinixic acid increases expression EXP   6480464 pirinixic acid results in increased expression of VIM mRNA CTD PMID:18301758 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:621646 6480464 Pregnenolone Carbonitrile results in decreased expression of VIM mRNA CTD PMID:19162173 pyrogallol increases expression EXP   6480464 Pyrogallol results in increased expression of VIM mRNA CTD PMID:20362636 pyrogallol multiple interactions EXP   6480464 Silymarin inhibits the reaction [Pyrogallol results in increased expression of VIM mRNA] CTD PMID:20362636 rel-(3R,5S)-fluvastatin multiple interactions ISO RGD:621646 6480464 fluvastatin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of VIM mRNA] CTD PMID:16452496 resveratrol decreases expression ISO RGD:733128 6480464 resveratrol results in decreased expression of VIM mRNA; more ... CTD PMID:22692956 resveratrol multiple interactions ISO RGD:733128 6480464 resveratrol inhibits the reaction [TGFB1 protein results in increased expression of VIM mRNA]; more ... CTD PMID:23146760 rosiglitazone affects expression ISO RGD:733128 6480464 rosiglitazone affects the expression of VIM protein CTD PMID:19556978 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:621646 6480464 S-(1,2-dichlorovinyl)cysteine results in increased expression of VIM mRNA CTD PMID:10996665 selenium atom increases expression ISO RGD:733128 6480464 Selenium results in increased expression of VIM mRNA CTD PMID:19244175 selenium atom increases expression ISO RGD:621646 6480464 Selenium deficiency results in increased expression of VIM protein CTD PMID:17109141 selenium atom multiple interactions ISO RGD:621646 6480464 Selenium inhibits the reaction [Cisplatin results in increased expression of VIM protein] CTD PMID:16837816 silver atom increases expression EXP   6480464 Silver results in increased expression of VIM mRNA CTD PMID:19429238 silver(0) increases expression EXP   6480464 Silver results in increased expression of VIM mRNA CTD PMID:19429238 simvastatin decreases expression EXP   6480464 Simvastatin results in decreased expression of VIM protein CTD PMID:14973129 simvastatin decreases expression ISO RGD:621646 6480464 Simvastatin results in decreased expression of VIM protein CTD PMID:15855201 sodium hydrogencarbonate multiple interactions ISO RGD:621646 6480464 Sodium Bicarbonate inhibits the reaction [Doxorubicin results in increased expression of VIM protein] CTD PMID:10430982 staurosporine multiple interactions ISO RGD:621646 6480464 Staurosporine inhibits the reaction [diphenylditelluride results in increased phosphorylation of VIM protein] CTD PMID:21879721 streptozocin multiple interactions ISO RGD:621646 6480464 carvedilol inhibits the reaction [Streptozocin results in increased expression of VIM protein] CTD PMID:12140129 streptozocin increases expression ISO RGD:621646 6480464 Streptozocin results in increased expression of VIM protein CTD PMID:12140129 sulfasalazine increases expression EXP   6480464 Sulfasalazine results in increased expression of VIM mRNA CTD PMID:22016648 sulforaphane increases metabolic processing ISO RGD:733128 6480464 sulforafan results in increased metabolism of VIM protein CTD PMID:21838287 sulforaphane affects binding ISO RGD:733128 6480464 VIM protein binds to sulforafan CTD PMID:21838287 tacrolimus hydrate increases expression ISO RGD:733128 6480464 Tacrolimus results in increased expression of VIM protein CTD PMID:22416070 tamibarotene decreases expression ISO RGD:733128 6480464 Am 80 results in decreased expression of VIM mRNA; more ... CTD PMID:15498508 tert-butyl hydroperoxide decreases expression ISO RGD:733128 6480464 tert-Butylhydroperoxide results in decreased expression of VIM protein CTD PMID:15050405 testosterone multiple interactions ISO RGD:733128 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of VIM mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:733128 6480464 Testosterone results in increased expression of VIM mRNA CTD PMID:21592394 tetrachloromethane increases expression EXP   6480464 Carbon Tetrachloride results in increased expression of VIM mRNA CTD PMID:18038451 PMID:15056808 tetrachloromethane increases expression EXP   6480464 Carbon Tetrachloride results in increased expression of VIM mRNA CTD PMID:15056808 PMID:18038451 tetrachloromethane affects expression ISO RGD:621646 6480464 Carbon Tetrachloride affects the expression of VIM mRNA CTD PMID:12734012 tetrachloromethane increases expression ISO RGD:621646 6480464 Carbon Tetrachloride results in increased expression of VIM protein CTD PMID:12629582 tetrachloromethane multiple interactions EXP   6480464 PPARD protein affects the reaction [Carbon Tetrachloride results in increased expression of VIM mRNA] CTD PMID:18038451 titanium dioxide decreases phosphorylation ISO RGD:733128 6480464 titanium dioxide results in decreased phosphorylation of VIM protein CTD PMID:21439344 topotecan affects response to substance ISO RGD:733128 6480464 VIM protein affects the susceptibility to Topotecan CTD PMID:16217747 trans-resveratrol decreases expression ISO RGD:733128 6480464 resveratrol results in decreased expression of VIM mRNA; more ... CTD PMID:22692956 trans-resveratrol multiple interactions ISO RGD:733128 6480464 resveratrol inhibits the reaction [TGFB1 protein results in increased expression of VIM mRNA]; more ... CTD PMID:23146760 trichloroethene decreases expression ISO RGD:621646 6480464 Trichloroethylene results in decreased expression of VIM mRNA CTD PMID:14565619 trichloroethene increases expression ISO RGD:621646 6480464 Trichloroethylene results in increased expression of VIM mRNA CTD PMID:10996665 trichostatin A multiple interactions ISO RGD:733128 6480464 trichostatin A inhibits the reaction [butylbenzyl phthalate promotes the reaction [[TCF4 protein binds to LEF1 protein] which binds to VIM protein]]; more ... CTD PMID:22552774 undecane increases expression ISO RGD:621646 6480464 undecane results in increased expression of VIM protein CTD PMID:17337753 valproic acid decreases expression ISO RGD:733128 6480464 Valproic Acid results in decreased expression of VIM protein CTD PMID:19628293 valproic acid affects expression ISO RGD:621646 6480464 Valproic Acid affects the expression of VIM protein CTD PMID:22142741 vancomycin increases expression ISO RGD:621646 6480464 Vancomycin results in increased expression of VIM mRNA CTD PMID:18289764 vancomycin decreases expression EXP   6480464 Vancomycin results in decreased expression of VIM mRNA CTD PMID:18930951 verapamil multiple interactions ISO RGD:621646 6480464 Verapamil inhibits the reaction [diphenylditelluride results in increased phosphorylation of VIM protein] CTD PMID:21879721 verapamil multiple interactions ISO RGD:621646 6480464 Verapamil inhibits the reaction [diphenylditelluride results in decreased phosphorylation of VIM protein] CTD PMID:21863293 Gene Ontology Annotations Biological Process Term Qualifier Evidence With Reference Notes Source Original Reference(s) astrocyte development   IGI MGI:MGI:95697 2290270 MGI:MGI:3719550|PMID:11487638 MGI MGI:MGI:3719550 PMID:11487638 Bergmann glial cell differentiation   IMP MGI:MGI:1931877 2290270 MGI:MGI:1858866|PMID:10816608 MGI MGI:MGI:1858866 PMID:10816608 intermediate filament organization   IGI MGI:MGI:95697 2290270 MGI:MGI:3719550|PMID:11487638 MGI MGI:MGI:3719550 PMID:11487638 intermediate filament-based process   IMP MGI:MGI:1931877 2290270 MGI:MGI:2384242|PMID:12177195 MGI MGI:MGI:2384242 PMID:12177195 lens fiber cell development   IDA   2290270 MGI:MGI:2673300|PMID:15037121 MGI MGI:MGI:2673300 PMID:15037121 negative regulation of neuron projection development   IGI MGI:MGI:95697 2290270 MGI:MGI:3719550|PMID:11487638 MGI MGI:MGI:3719550 PMID:11487638 positive regulation of glial cell proliferation   ISO UniProtKB:P31000 2290270 MGI:MGI:4417868 RGD MGI:MGI:4417868 regulation of axonogenesis   ISO UniProtKB:P31000 2290270 MGI:MGI:4417868 RGD MGI:MGI:4417868 regulation of Schwann cell migration   ISO UniProtKB:P31000 2290270 MGI:MGI:4417868 RGD MGI:MGI:4417868 Cellular Component Term Qualifier Evidence With Reference Notes Source Original Reference(s) axon   ISO UniProtKB:P31000 2290270 MGI:MGI:4417868 RGD MGI:MGI:4417868 cell body   ISO UniProtKB:P31000 2290270 MGI:MGI:4417868 RGD MGI:MGI:4417868 cell leading edge   IDA   2290270 MGI:MGI:3588480|PMID:15958512 MGI MGI:MGI:3588480 PMID:15958512 cell projection   IDA   2290270 MGI:MGI:2157598|PMID:10989258 MGI MGI:MGI:2157598 PMID:10989258 cell projection   ISO UniProtKB:P31000 2290270 MGI:MGI:4417868 RGD MGI:MGI:4417868 cytoplasm   IDA   2290270 MGI:MGI:3583881|PMID:15965470 MGI MGI:MGI:3583881 PMID:15965470 cytoplasm   ISO UniProtKB:P08670 2290270 MGI:MGI:4834177 MGI MGI:MGI:4834177 cytoplasm   ISO UniProtKB:P31000 2290270 MGI:MGI:4417868 RGD MGI:MGI:4417868 cytoskeleton   ISO UniProtKB:P08670 2290270 MGI:MGI:3694330|PMID:16769727 MGI MGI:MGI:3694330 PMID:16769727 cytoskeleton   ISO UniProtKB:P31000 2290270 MGI:MGI:4417868 RGD MGI:MGI:4417868 cytosol   ISO UniProtKB:P08670 2290270 MGI:MGI:4834177 MGI MGI:MGI:4834177 cytosol   ISO UniProtKB:P31000 2290270 MGI:MGI:4417868 RGD MGI:MGI:4417868 extracellular vesicular exosome   ISO UniProtKB:P08670 2290270 MGI:MGI:4834177 MGI MGI:MGI:4834177 intermediate filament   IDA   2290270 MGI:MGI:64973|PMID:8188282 MGI MGI:MGI:64973 PMID:8188282 intermediate filament   ISO UniProtKB:P08670 2290270 MGI:MGI:4834177 MGI MGI:MGI:4834177 intermediate filament   IDA   2290270 MGI:MGI:4439000|PMID:20103531 MGI MGI:MGI:4439000 PMID:20103531 intermediate filament   IDA   2290270 MGI:MGI:3719550|PMID:11487638 MGI MGI:MGI:3719550 PMID:11487638 intermediate filament   IDA   2290270 MGI:MGI:2673300|PMID:15037121 MGI MGI:MGI:2673300 PMID:15037121 intermediate filament   IDA   2290270 MGI:MGI:3761040|PMID:17882221 MGI MGI:MGI:3761040 PMID:17882221 intermediate filament   IDA   2290270 MGI:MGI:76118|PMID:2493000 MGI MGI:MGI:76118 PMID:2493000 intermediate filament cytoskeleton   ISO UniProtKB:B0YJC4 2290270 MGI:MGI:4834177 MGI MGI:MGI:4834177 perinuclear region of cytoplasm   ISO UniProtKB:P31000 2290270 MGI:MGI:4417868 RGD MGI:MGI:4417868 peroxisome   ISO UniProtKB:P08670 2290270 MGI:MGI:4834177 MGI MGI:MGI:4834177 type III intermediate filament   TAS   2290270 MGI:MGI:2384242|PMID:12177195 MGI MGI:MGI:2384242 PMID:12177195 Molecular Function Term Qualifier Evidence With Reference Notes Source Original Reference(s) identical protein binding   ISO UniProtKB:P08670 2290270 MGI:MGI:4834177 MGI MGI:MGI:4834177 kinase binding   ISO UniProtKB:P31000 2290270 MGI:MGI:4417868 RGD MGI:MGI:4417868 protein binding   IPI UniProtKB:Q9R269 2290270 MGI:MGI:3838237|PMID:19029034 MGI MGI:MGI:3838237 PMID:19029034 protein binding   IPI UniProtKB:P35465 2290270 MGI:MGI:3694137|PMID:11895474 IntAct MGI:MGI:3694137 PMID:11895474 protein binding   IPI UniProtKB:Q70IV5 2290270 MGI:MGI:3713044|PMID:17356066 UniProtKB MGI:MGI:3713044 PMID:17356066 protein binding   IPI UniProtKB:Q9R269 2290270 MGI:MGI:3687908|PMID:12244133 IntAct MGI:MGI:3687908 PMID:12244133 protein C-terminus binding   ISO UniProtKB:P08670 2290270 MGI:MGI:4834177 MGI MGI:MGI:4834177 protein kinase binding   ISO UniProtKB:P31000 2290270 MGI:MGI:4417868 RGD MGI:MGI:4417868 protein phosphatase 2A binding   ISO UniProtKB:P31000 2290270 MGI:MGI:4417868 RGD MGI:MGI:4417868 scaffold protein binding   ISO UniProtKB:P08670 2290270 MGI:MGI:4834177 MGI MGI:MGI:4834177 structural constituent of cytoskeleton   ISO UniProtKB:P08670 2290270 MGI:MGI:4834177 MGI MGI:MGI:4834177 structural constituent of eye lens   IDA   2290270 MGI:MGI:2673300|PMID:15037121 MGI MGI:MGI:2673300 PMID:15037121 structural molecule activity   IMP MGI:MGI:1931877 2290270 MGI:MGI:2384242|PMID:12177195 MGI MGI:MGI:2384242 PMID:12177195 Molecular Pathway Annotations External Database Links KEGG Pathway Epstein-Barr virus infection Pathway Interaction Database Aurora B signaling (PID:200012) Caspase cascade in apoptosis (PID:200173) Phenotype Annotations Term Qualifier Evidence With Reference Notes Source Original Reference(s) abnormal angiogenesis   IAGP   5509061   MGI PMID:10712381 abnormal astrocyte morphology   IAGP   5509061   MGI PMID:12177195 abnormal astrocyte morphology   IAGP   5509061   MGI PMID:11701765 abnormal astrocyte physiology   IAGP   5509061   MGI PMID:11701765 abnormal blood vessel morphology   IAGP   5509061   MGI PMID:16429129 abnormal brain morphology   IAGP   5509061   MGI PMID:22031903 abnormal cell migration   IAGP   5509061   MGI PMID:9625752 abnormal cell morphology   IAGP   5509061   MGI PMID:9625752 abnormal cell physiology   IAGP   5509061   MGI PMID:9625752 abnormal cellular extravasation   IAGP   5509061   MGI PMID:16429129 abnormal cerebellar Purkinje cell layer   IAGP   5509061   MGI PMID:9888296 abnormal cerebellum morphology   IAGP   5509061   MGI PMID:9888296 abnormal CNS glial cell morphology   IAGP   5509061   MGI PMID:12177195 abnormal cytokine level   IAGP   5509061   MGI PMID:22031903 abnormal dentate gyrus morphology   IAGP   5509061   MGI PMID:15662841 abnormal leukocyte adhesion   IAGP   5509061   MGI PMID:16429129 abnormal leukocyte migration   IAGP   5509061   MGI PMID:16429129 abnormal leukocyte tethering or rolling   IAGP   5509061   MGI PMID:16429129 abnormal locomotor behavior   IAGP   5509061   MGI PMID:9888296 abnormal motor learning   IAGP   5509061   MGI PMID:9888296 abnormal nervous system morphology   IAGP   5509061   MGI PMID:22031903 abnormal neuron differentiation   IAGP   5509061   MGI PMID:15662841 abnormal neuron differentiation   IAGP   5509061   MGI PMID:20963821 abnormal Purkinje cell dendrite morphology   IAGP   5509061   MGI PMID:9888296 abnormal Purkinje cell morphology   IAGP   5509061   MGI PMID:9888296 abnormal spinal cord morphology   IAGP   5509061   MGI PMID:10225952 abnormal vasoconstriction   IAGP   5509061   MGI PMID:9294120 abnormal vasodilation   IAGP   5509061   MGI PMID:9294120 abnormal visual cortex morphology   IAGP   5509061   MGI PMID:22031903 astrocytosis   IAGP   5509061   MGI PMID:10225952 brain inflammation   IAGP   5509061   MGI PMID:22031903 decreased brain weight   IAGP   5509061   MGI PMID:22031903 decreased inflammatory response   IAGP   5509061   MGI PMID:17525210 decreased mean systemic arterial blood pressure   IAGP   5509061   MGI PMID:9294120 decreased neuron apoptosis   IAGP   5509061   MGI PMID:17525210 decreased Purkinje cell number   IAGP   5509061   MGI PMID:9888296 gliosis   IAGP   5509061   MGI PMID:17525210 hippocampal neuron degeneration   IAGP   5509061   MGI PMID:22031903 hyperactivity   IAGP   5509061   MGI PMID:9888296 impaired balance   IAGP   5509061   MGI PMID:9888296 impaired coordination   IAGP   5509061   MGI PMID:9888296 increased anxiety-related response   IAGP   5509061   MGI PMID:9888296 increased circulating creatinine level   IAGP   5509061   MGI PMID:9294120 increased sensitivity to induced morbidity/mortality   IAGP   5509061   MGI PMID:9294120 increased vasodilation   IAGP   5509061   MGI PMID:10225952 intracranial hemorrhage   IAGP   5509061   MGI PMID:10225952 neurodegeneration   IAGP   5509061   MGI PMID:22031903 premature death   IAGP   5509061   MGI PMID:22031903 Purkinje cell degeneration   IAGP   5509061   MGI PMID:9888296 thin cerebral cortex   IAGP   5509061   MGI PMID:22031903 Disease Annotations Alzheimer Disease  (IEP,ISS) Arthritis, Experimental  (ISS) Arthritis, Rheumatoid  (ISS) Atherosclerosis  (ISS) Behcet Syndrome  (ISS) Brain Infarction  (ISS) Brain Injuries  (IEP,ISS) Cataract  (ISS) Chagas Disease  (ISS) Coronary Artery Disease  (ISS) Fever  (ISS) Gliosis  (ISS) Head Injuries, Closed  (ISS) Head Injuries, Penetrating  (IPM) Hyperthyroidism  (ISS) Liver Neoplasms, Experimental  (ISS) Lupus Erythematosus, Systemic  (ISS) Nephrosis  (ISS) Sjogren's Syndrome  (ISS) Spinal Cord Injuries  (IPM,ISS) Urination Disorders  (ISS) Gene-Chemical Interaction Annotations (3S,5R)-fluvastatin  (ISO) (S)-nicotine  (ISO) 1,3-dinitrobenzene  (ISO) 17alpha-ethynylestradiol  (EXP) 2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO) 2-naphthylamine  (ISO) 2-nitrofluorene  (ISO) 3',5'-cyclic GMP  (EXP) 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine  (ISO) 3H-1,2-dithiole-3-thione  (ISO) 4,4'-diaminodiphenylmethane  (EXP,ISO) 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one  (ISO) 4-hydroperoxycyclophosphamide  (EXP) 4-hydroxynon-2-enal  (ISO) 4-hydroxyphenyl retinamide  (ISO) 5-aza-2'-deoxycytidine  (ISO) 5-azacytidine  (ISO) 6-propyl-2-thiouracil  (ISO) acetylcholine  (EXP) acrolein  (ISO) aflatoxin B1  (EXP) all-trans-retinoic acid  (EXP,ISO) ammonium chloride  (ISO) andrographolide  (EXP) arsenite(3-)  (ISO) bacitracin  (ISO) bathocuproine disulfonic acid  (ISO) benzo[a]pyrene  (EXP,ISO) bis(2-ethylhexyl) phthalate  (EXP,ISO) bisphenol A  (ISO) cadmium atom  (ISO) cadmium dichloride  (ISO) calciol  (ISO) calcitriol  (ISO) calcium atom  (ISO) calcium(0)  (ISO) capsaicin  (ISO) carboplatin  (ISO) carvedilol  (ISO) choline  (EXP) cis-ketoconazole  (ISO) cisplatin  (ISO) clofibrate  (ISO) clofibric acid  (ISO) cobalt dichloride  (ISO) copper atom  (EXP,ISO) copper(0)  (EXP,ISO) cyclophosphamide  (ISO) cyclosporin A  (EXP) cypermethrin  (EXP) D-glucose  (ISO) dantrolene  (ISO) daunorubicin  (ISO) DDT  (ISO) Delta(9)-tetrahydrocannabinol  (ISO) dexamethasone  (EXP) diazoxide  (EXP) dibutyl phthalate  (EXP,ISO) dichromium trioxide  (ISO) diclofenac  (ISO) diethylstilbestrol  (EXP) disodium selenite  (ISO) doxorubicin  (EXP,ISO) elemental selenium  (ISO) endosulfan  (ISO) ethanol  (ISO) ethylene glycol bis(2-aminoethyl)tetraacetic acid  (ISO) folic acid  (EXP) glucose  (ISO) heptachlor  (ISO) heptadecafluorononanoic acid  (ISO) hyaluronic acid  (EXP,ISO) hydrogen peroxide  (ISO) indole-3-methanol  (ISO) indomethacin  (EXP,ISO) ionomycin  (ISO) isoprenaline  (EXP) L-ascorbic acid  (EXP) L-methionine  (EXP) lead diacetate  (ISO) lithium chloride  (ISO) methimazole  (ISO) microcystin-LR  (ISO) mono(2-ethylhexyl) phthalate  (ISO) morphine  (ISO) N(6)-dimethylallyladenine  (ISO) N-methyl-N'-nitro-N-nitrosoguanidine  (ISO) N-nitrosodiethylamine  (EXP,ISO) N-nitrosodimethylamine  (ISO) nifedipine  (ISO) ochratoxin A  (EXP,ISO) oxcarbazepine  (ISO) ozone  (ISO) paracetamol  (EXP) phenethyl isothiocyanate  (ISO) phenobarbital  (EXP,ISO) phenytoin  (ISO) phorbol 13-acetate 12-myristate  (ISO) pirinixic acid  (EXP) pregnenolone 16alpha-carbonitrile  (ISO) pyrogallol  (EXP) rel-(3R,5S)-fluvastatin  (ISO) resveratrol  (ISO) rosiglitazone  (ISO) S-(1,2-dichlorovinyl)-L-cysteine  (ISO) selenium atom  (ISO) silver atom  (EXP) silver(0)  (EXP) simvastatin  (EXP,ISO) sodium hydrogencarbonate  (ISO) staurosporine  (ISO) streptozocin  (ISO) sulfasalazine  (EXP) sulforaphane  (ISO) tacrolimus hydrate  (ISO) tamibarotene  (ISO) tert-butyl hydroperoxide  (ISO) testosterone  (ISO) tetrachloromethane  (EXP,ISO) titanium dioxide  (ISO) topotecan  (ISO) trans-resveratrol  (ISO) trichloroethene  (ISO) trichostatin A  (ISO) undecane  (ISO) valproic acid  (ISO) vancomycin  (EXP,ISO) verapamil  (ISO) Gene Ontology Annotations Biological Process astrocyte development  (IGI) Bergmann glial cell differentiation  (IMP) intermediate filament organization  (IGI) intermediate filament-based process  (IMP) lens fiber cell development  (IDA) negative regulation of neuron projection development  (IGI) positive regulation of glial cell proliferation  (ISO) regulation of axonogenesis  (ISO) regulation of Schwann cell migration  (ISO) Cellular Component axon  (ISO) cell body  (ISO) cell leading edge  (IDA) cell projection  (IDA,ISO) cytoplasm  (IDA,ISO) cytoskeleton  (ISO) cytosol  (ISO) extracellular vesicular exosome  (ISO) intermediate filament  (IDA,ISO) intermediate filament cytoskeleton  (ISO) perinuclear region of cytoplasm  (ISO) peroxisome  (ISO) type III intermediate filament  (TAS) Molecular Function identical protein binding  (ISO) kinase binding  (ISO) protein binding  (IPI) protein C-terminus binding  (ISO) protein kinase binding  (ISO) protein phosphatase 2A binding  (ISO) scaffold protein binding  (ISO) structural constituent of cytoskeleton  (ISO) structural constituent of eye lens  (IDA) structural molecule activity  (IMP) Molecular Pathway Annotations External Database Links KEGG Pathway Epstein-Barr virus infection Pathway Interaction Database Aurora B signaling (PID:200012) Caspase cascade in apoptosis (PID:200173) Phenotype Annotations abnormal angiogenesis  (IAGP) abnormal astrocyte morphology  (IAGP) abnormal astrocyte physiology  (IAGP) abnormal blood vessel morphology  (IAGP) abnormal brain morphology  (IAGP) abnormal cell migration  (IAGP) abnormal cell morphology  (IAGP) abnormal cell physiology  (IAGP) abnormal cellular extravasation  (IAGP) abnormal cerebellar Purkinje cell layer  (IAGP) abnormal cerebellum morphology  (IAGP) abnormal CNS glial cell morphology  (IAGP) abnormal cytokine level  (IAGP) abnormal dentate gyrus morphology  (IAGP) abnormal leukocyte adhesion  (IAGP) abnormal leukocyte migration  (IAGP) abnormal leukocyte tethering or rolling  (IAGP) abnormal locomotor behavior  (IAGP) abnormal motor learning  (IAGP) abnormal nervous system morphology  (IAGP) abnormal neuron differentiation  (IAGP) abnormal Purkinje cell dendrite morphology  (IAGP) abnormal Purkinje cell morphology  (IAGP) abnormal spinal cord morphology  (IAGP) abnormal vasoconstriction  (IAGP) abnormal vasodilation  (IAGP) abnormal visual cortex morphology  (IAGP) astrocytosis  (IAGP) brain inflammation  (IAGP) decreased brain weight  (IAGP) decreased inflammatory response  (IAGP) decreased mean systemic arterial blood pressure  (IAGP) decreased neuron apoptosis  (IAGP) decreased Purkinje cell number  (IAGP) gliosis  (IAGP) hippocampal neuron degeneration  (IAGP) hyperactivity  (IAGP) impaired balance  (IAGP) impaired coordination  (IAGP) increased anxiety-related response  (IAGP) increased circulating creatinine level  (IAGP) increased sensitivity to induced morbidity/mortality  (IAGP) increased vasodilation  (IAGP) intracranial hemorrhage  (IAGP) neurodegeneration  (IAGP) premature death  (IAGP) Purkinje cell degeneration  (IAGP) thin cerebral cortex  (IAGP) References - curated 1. Akoglu T, etal., Clin Immunol Immunopathol. 1986 Dec;41(3):427-32. 2. Baldwin SA and Scheff SW, Glia. 1996 Mar;16(3):266-75. 3. Bechtold DA and Brown IR, Neurochem Res 2003 Aug;28(8):1163-73. 4. El-Barbary AM, etal., J Rheumatol. 2011 May;38(5):828-34. Epub 2011 Mar 1. 5. Franch A, etal., J Rheumatol. 1994 Mar;21(3):489-97. 6. Kelso ML, etal., Neuroscience. 2011 Dec 1;197:381-93. Epub 2011 Sep 16. 7. Kurki P, etal., J Rheumatol. 1983 Aug;10(4):558-62. 8. Levin EC, etal., Brain Res. 2009 Nov 17;1298:194-207. Epub 2009 Sep 1. 9. Lin J and Cai W, J Neurotrauma. 2004 Nov;21(11):1671-82. 10. MGD data from the GO Consortium 11. Moon C, etal., Brain Res. 2004 Dec 3;1028(2):238-42. 12. Nakamura Y, etal., Int J Cancer. 2009 Jun 1;124(11):2512-9. 13. Pekny M, etal., J Cell Biol. 1999 May 3;145(3):503-14. 14. Poduri A, etal., Mol Cell Biochem. 2012 Jan;360(1-2):181-8. Epub 2011 Sep 22. 15. RGD automated import pipeline 16. RGD automated import pipeline for gene-chemical interactions 17. RGD Automated Pipelines 18. Toyooka T, etal., J Neurotrauma. 2011 Apr;28(4):607-18. Epub 2011 Mar 24. 19. van de Stadt LA, etal., Arthritis Rheum. 2011 Nov;63(11):3226-33. doi: 10.1002/art.30537. 20. Wen JJ and Garg NJ, Mol Cell Proteomics. 2011 Dec 22. 21. Zamoner A, etal., Mol Cell Endocrinol. 2007 Mar 15;267(1-2):116-26. Epub 2007 Jan 20. 22. Zamoner A, etal., Steroids. 2008 Dec 22;73(14):1400-8. Epub 2008 Jul 17. 23. Zou J, etal., Virchows Arch. 2006 Apr;448(4):485-92. Epub 2006 Jan 18. References - uncurated PubMed 10029587   10102687   10349636   10446168   10512984   10559638   10712381   10816608   10852824   10922068   10984437   10989258   11042159   11044609   11076861   11171335   11217851   11279275   11307167   11321598   11414789   11475331   11487638   11493566   11514563   11520676   11566879   11696558   11701765   11706940   11747604   11807023   11865027   11895474   11932925   12128098   12149647   12160147   12177195   12221011   12223406   12244133   12426373   12453462   12458200   12466851   12477932   12586425   12724835   12861073   1315305   1372074   1385302   14595844   14610273   14641326   14660441   14681479   14706695   14729942   15026142   15037121   15207855   15226376   15238351   15251432   15261829   15280211   15450850   15634788   15662841   15713670   15731004   15748847   15749887   15782199   15797020   15809042   15817462   15899914   15958512   15965470   15972963   1611218   16141072   16141073   16196028   16270034   16373170   16387639   16429129   16458080   1655359   16602821   16702404   16769727   1676977   1680375   16884701   16980969   17015463   17101724   17108173   17189626   17192421   17192600   17224453   17251187   17270292   17313568   17356066   17467685   17525210   17533120   17589506   17604020   17676644   17680824   17882221   17932483   18090917   18094027   18178558   18192284   18214994   18231966   18308476   18351630   18358466   18371380   18371946   18469190   18469343   1850997   18568073   18599437   18729210   18806271   18830900   18848541   18849992   18940912   18948621   19029034   19141476   1916246   19217425   19223297   19291697   19302980   19367791   19373938   19403928   19420356   19445942   19498055   19560548   19596361   19631635   19633665   19640478   19656809   19680541   19726676   19739253   19743445   19752599   19796621   19820125   19838179   19841136   19998061   20023660   20103531   20143880   20170731   20353824   20382123   20410206   20436479   20442854   20473291   20479526   20544856   20549747   20678473   20687112   20691176   20697379   20702585   20823249   20869363   20934536   20935171   20963821   20974670   21118511   21147077   21181199   21186337   21194568   21216232   21242963   21287656   21346197   21347296   21378307   21402174   2140597   21490060   21508962   21510876   21512159   21513708   21525288   21562225   21565611   21624358   21659647   21677750   21709251   21746880   21750042   21803052   21828285   21835343   21849552   21966382   22024319   22031903   22071110   22090492   22117063   22194995   22267199   22354480   22357929   22360968   22366455   22395070   22421048   22476899   22535408   22535769   22546693   22560297   22681613   22682244   22730381   22745758   22887872   22906538   22952236   22980982   23100423   23135265   2325630   23341629   23345421   2493000   2500966   2744479   2767427   6161051   7523108   7533563   7665181   7691937   7720210   7766993   7890332   7954832   8070623   8170478   8188282   8261138   8307566   8314004   8318736   8358169   8449489   8486356   8530383   8543176   8543661   8597644   8609166   8630490   8634150   8651505   8666670   8692820   9011744   9117989   9143510   9294120   9314534   9389758   9415485   9504050   9625752   9671659   9795147   9888296 RGD Disease Portals Vim has been annotated in the following RGD Disease Portals. Biological Process Cardiovascular Diseases Cardiovascular Phenotypes Diabetes Phenotypes Immune and Inflammatory Diseases Immune and Inflammatory Phenotypes Biological Process Neurological Diseases Neurological Phenotypes Obesity Diseases Obesity Phenotypes Genomics Comparative Map Data Vim   (Mus musculus) Map Chr Position Strand Source Mouse Genome Assembly GRCm38 2 13,574,311 - 13,582,826 + NCBI Mouse cM Map 2 10.04   NCBI Mouse Celera Assembly 2 13,484,803 - 13,493,320 + NCBI Mouse Genome Assembly Build 37 2 13,495,938 - 13,504,453 + NCBI Mouse Genome Assembly Build 36.1 2 13,495,579 - 13,504,434 + NCBI Mouse Cytogenetic Map 2 A2   NCBI VIM   (Homo sapiens) Map Chr Position Strand Source Human Alternate Assembly CHM1_1 10 17,178,818 - 17,188,151 + NCBI Human Genome Assembly HuRef 10 17,183,488 - 17,192,823 + NCBI Human Genome Assembly GRCh37 10 17,270,258 - 17,279,592 + NCBI Human Genome Assembly Build 36 10 17,311,304 - 17,319,598 + NCBI Human Cytogenetic Map 10 p13   NCBI Human Genome Assembly 10 17,311,308 - 17,319,594   NCBI Vim   (Rattus norvegicus) Map Chr Position Strand Source Rat Cytogenetic Map 17 q12.3   NCBI RGSC Genome Assembly v5.0 17 82,500,898 - 82,509,383 + NCBI RGSC Genome Assembly v3.4 17 87,847,280 - 87,855,763 + NCBI Rat Celera Assembly 17 76,037,845 - 76,046,329 + NCBI Genome Assembly 3.1 17 87,858,112 - 87,866,596 + NCBI Position Markers Vim   Map Chr Position Strand Source Mouse Genome Assembly GRCm38 2 13,578,424 - 13,578,631   UniSTS Mouse cM Map 2 7.0   UniSTS Mouse cM Map 2 7.0   UniSTS Mouse Celera Assembly 2 13,488,916 - 13,489,123   UniSTS Mouse Genome Assembly Build 37 2 13,500,051 - 13,500,258   UniSTS Mouse Cytogenetic Map 2 A2   UniSTS Vim   Map Chr Position Strand Source Mouse Cytogenetic Map 2 A2   UniSTS Vim   Map Chr Position Strand Source Mouse cM Map 2 7.0   UniSTS Mouse Cytogenetic Map 2 A2   UniSTS VIM   Map Chr Position Strand Source Mouse Genome Assembly GRCm38 2 13,578,415 - 13,578,664   UniSTS Mouse Celera Assembly 2 13,488,907 - 13,489,156   UniSTS Mouse Genome Assembly Build 37 2 13,500,042 - 13,500,291   UniSTS Mouse Cytogenetic Map 2 A2   UniSTS Vim   Map Chr Position Strand Source Mouse Cytogenetic Map 2 A2   UniSTS QTLs in Region (Mouse Genome Assembly Build 37) The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer RGD ID Symbol Name LOD P Value Trait Sub Trait Chr Start Stop Species 1300624 Insq7_m insulin QTL 7 (mouse) Not determined 2 9349954 43350083 Mouse 1302169 Ptz1b_m pentylenetetrazol induced seizure susceptibility 1b (mouse) Not determined 2 8905794 42905916 Mouse 4142037 Etax3_m ethanol induced ataxia 3 (mouse) Not determined 2 8273559 42273748 Mouse 1301790 Pcfm1_m periosteal circumference and femur length 1 (mouse) Not determined 2 8201804 42201904 Mouse 1301980 Fcsa5_m femoral cross-sectional area 5 (mouse) Not determined 2 7644623 41644769 Mouse 1558729 Vacq3_m voluntary alcohol consumption QTL 3 (mouse) Not determined 2 1 26270272 Mouse 1301147 Diet1_m variability in response to cholestrol enriched atherogenic diet (mouse) Not determined 2 1 25665397 Mouse 1302167 Aaiq3_m aromatase activity QTL 3 (mouse) Not determined 2 1 21519232 Mouse 4142337 Adip10_m adiposity 10 (mouse) Not determined 2 1 20803483 Mouse Sequence Nucleotide Sequences Nucleotide RefSeqs NM_011701 (Get FASTA) Search GEO for Microarray Profiles GenBank Nucleotide AAHY01014057 (Get FASTA) Search GEO for Microarray Profiles   AK012469 (Get FASTA) Search GEO for Microarray Profiles   AK033175 (Get FASTA) Search GEO for Microarray Profiles   AK076001 (Get FASTA) Search GEO for Microarray Profiles   AK131618 (Get FASTA) Search GEO for Microarray Profiles   AK133726 (Get FASTA) Search GEO for Microarray Profiles   AK150270 (Get FASTA) Search GEO for Microarray Profiles   AK151196 (Get FASTA) Search GEO for Microarray Profiles   AK153019 (Get FASTA) Search GEO for Microarray Profiles   AK159539 (Get FASTA) Search GEO for Microarray Profiles   AK169181 (Get FASTA) Search GEO for Microarray Profiles   AK170429 (Get FASTA) Search GEO for Microarray Profiles   AK179855 (Get FASTA) Search GEO for Microarray Profiles   AK181650 (Get FASTA) Search GEO for Microarray Profiles   AK188217 (Get FASTA) Search GEO for Microarray Profiles   AK196009 (Get FASTA) Search GEO for Microarray Profiles   AK197870 (Get FASTA) Search GEO for Microarray Profiles   AK198215 (Get FASTA) Search GEO for Microarray Profiles   AK203726 (Get FASTA) Search GEO for Microarray Profiles   AK203908 (Get FASTA) Search GEO for Microarray Profiles   AK205443 (Get FASTA) Search GEO for Microarray Profiles   AK205778 (Get FASTA) Search GEO for Microarray Profiles   AK205873 (Get FASTA) Search GEO for Microarray Profiles   AK207271 (Get FASTA) Search GEO for Microarray Profiles   AK208041 (Get FASTA) Search GEO for Microarray Profiles   AK208074 (Get FASTA) Search GEO for Microarray Profiles   AK209588 (Get FASTA) Search GEO for Microarray Profiles   AK209779 (Get FASTA) Search GEO for Microarray Profiles   AK210390 (Get FASTA) Search GEO for Microarray Profiles   AK210884 (Get FASTA) Search GEO for Microarray Profiles   AK212337 (Get FASTA) Search GEO for Microarray Profiles   AK212338 (Get FASTA) Search GEO for Microarray Profiles   AK212686 (Get FASTA) Search GEO for Microarray Profiles   AK212907 (Get FASTA) Search GEO for Microarray Profiles   AK213561 (Get FASTA) Search GEO for Microarray Profiles   AK213831 (Get FASTA) Search GEO for Microarray Profiles   AK216501 (Get FASTA) Search GEO for Microarray Profiles   AK217097 (Get FASTA) Search GEO for Microarray Profiles   AK217953 (Get FASTA) Search GEO for Microarray Profiles   AK218080 (Get FASTA) Search GEO for Microarray Profiles   AK218318 (Get FASTA) Search GEO for Microarray Profiles   AL772303 (Get FASTA) Search GEO for Microarray Profiles   BC089335 (Get FASTA) Search GEO for Microarray Profiles   BC134386 (Get FASTA) Search GEO for Microarray Profiles   CH466542 (Get FASTA) Search GEO for Microarray Profiles   D50805 (Get FASTA) Search GEO for Microarray Profiles   M24849 (Get FASTA) Search GEO for Microarray Profiles   M26251 (Get FASTA) Search GEO for Microarray Profiles   X51438 (Get FASTA) Search GEO for Microarray Profiles   X56397 (Get FASTA) Search GEO for Microarray Profiles   Y07738 (Get FASTA) Search GEO for Microarray Profiles   Z22526 (Get FASTA) Search GEO for Microarray Profiles Reference Sequences RefSeq Acc Id: NM_011701 RefSeq Status: PROVISIONAL Type: CODING Protein Acc Id: NP_035831 Position: Map Chr Position Strand Source Mouse Genome Assembly GRCm38 2 13,574,311 - 13,582,826 + ENTREZGENE Mouse cM Map 2   + ENTREZGENE Mouse Celera Assembly 2 13,484,803 - 13,493,320 + RGD Mouse Genome Assembly Build 37 2 13,495,938 - 13,504,453 + RGD Protein Sequences Protein RefSeqs NP_035831 (Get FASTA) GenBank Protein AAA40555 (Get FASTA)   AAA40556 (Get FASTA)   AAH89335 (Get FASTA)   AAI34387 (Get FASTA)   BAA19834 (Get FASTA)   BAC28181 (Get FASTA)   BAE20723 (Get FASTA)   BAE21803 (Get FASTA)   BAE29426 (Get FASTA)   BAE30193 (Get FASTA)   BAE31653 (Get FASTA)   BAE35166 (Get FASTA)   BAE40959 (Get FASTA)   BAE41790 (Get FASTA)   CAA35803 (Get FASTA)   CAA39807 (Get FASTA)   CAA69019 (Get FASTA)   CAA80251 (Get FASTA)   EDL08053 (Get FASTA)   EDL08054 (Get FASTA)   P20152 (Get FASTA) Promoters RGD ID: 6833063 Promoter ID: MM_KWN:27803 Type: CpG-Island SO ACC ID: SO:0000170 Source: MPROMDB Tissues & Cell Lines: 3T3L1_Day0,   3T3L1_Day1,   3T3L1_Day2,   3T3L1_Day3,   3T3L1_Day4,   3T3L1_Day6,   BoneMarrow_0Hour,   BoneMarrow_2Hour,   BoneMarrow_4Hour,   Brain,   ES_Cell,   Kidney,   Liver,   Lung,   MEF_B4,   MEF_B6,   Spleen Transcripts: ENSMUST00000028062,   OTTMUST00000026366,   OTTMUST00000026367 Position: Map Chr Position Strand Source Mouse Genome Assembly Build 36.1 2 13,494,756 - 13,496,597 + MPROMDB RGD ID: 6874268 Promoter ID: EPDNEW_M584 Type: preliminary Name: Vim_1 Description: vimentin SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) Position: Map Chr Position Strand Source Mouse Genome Assembly Build 36.1 2 13,495,934 - 13,495,994   EPDNEW RGD ID: 6833066 Promoter ID: MM_KWN:27804 Type: Non-CpG SO ACC ID: SO:0000170 Source: MPROMDB Tissues & Cell Lines: 3T3L1_Day0,   3T3L1_Day1,   3T3L1_Day2,   3T3L1_Day3,   BoneMarrow_0Hour,   BoneMarrow_2Hour,   BoneMarrow_4Hour,   Brain,   Kidney,   Lung,   MEF_B4,   MEF_B6 Transcripts: OTTMUST00000026368 Position: Map Chr Position Strand Source Mouse Genome Assembly Build 36.1 2 13,500,091 - 13,501,477 + MPROMDB RGD ID: 6847707 Promoter ID: MM_ACW:27537 Type: Non-CpG SO ACC ID: SO:0000170 Source: MPROMDB Tissues & Cell Lines: 3T3L1_Day0,   3T3L1_Day1,   3T3L1_Day3,   BoneMarrow_0Hour,   BoneMarrow_2Hour,   BoneMarrow_4Hour,   Lung,   MEF_B4,   MEF_B6 Transcripts: VIM.FSEP07 Position: Map Chr Position Strand Source Mouse Genome Assembly Build 36.1 2 13,501,549 - 13,502,049 + MPROMDB RGD ID: 6847708 Promoter ID: MM_ACW:27538 Type: Non-CpG SO ACC ID: SO:0000170 Source: MPROMDB Tissues & Cell Lines: 3T3L1_Day0,   3T3L1_Day1,   3T3L1_Day2,   3T3L1_Day3,   BoneMarrow_0Hour,   BoneMarrow_2Hour,   MEF_B4,   MEF_B6 Transcripts: VIM.HSEP07-UNSPLICED Position: Map Chr Position Strand Source Mouse Genome Assembly Build 36.1 2 13,502,976 - 13,504,247 + MPROMDB Additional Information External Database Links Database Acc Id Source(s) Ensembl Genes ENSMUSG00000026728 ENTREZGENE Ensembl Protein ENSMUSP00000028062 ENTREZGENE Ensembl Transcript ENSMUST00000028062 ENTREZGENE Entrez Gene 22352 ENTREZGENE Germonline ENSMUSG00000026728 HomoloGene Group ID 2538 ENTREZGENE InterPro Intermed_filament_DNA-bd UniProtKB/Swiss-Prot   Intermediate_filament_CS UniProtKB/Swiss-Prot   IPR001664 UniProtKB/Swiss-Prot   IPR016044 UniProtKB/Swiss-Prot IPI IPI00227299 UniProtKB/Swiss-Prot   IPI00751833 UniProtKB/TrEMBL   IPI00988539 UniProtKB/TrEMBL KEGG Report mmu:22352 ENTREZGENE, UniProtKB/Swiss-Prot MGD MGI:98932 ENTREZGENE PANTHER PTHR23239 UniProtKB/Swiss-Prot Pfam Filament UniProtKB/Swiss-Prot   Filament_head UniProtKB/Swiss-Prot PROSITE PS00226 UniProtKB/Swiss-Prot UniGene Mm.268000 ENTREZGENE UniProt A2AKJ2_MOUSE UniProtKB/TrEMBL   A4IF59_MOUSE UniProtKB/TrEMBL   Q3TFD9_MOUSE UniProtKB/TrEMBL   Q3TWV0_MOUSE UniProtKB/TrEMBL   Q3U6S1_MOUSE UniProtKB/TrEMBL   Q3UAX1_MOUSE UniProtKB/TrEMBL   Q3UD36_MOUSE UniProtKB/TrEMBL   Q3V2S4_MOUSE UniProtKB/TrEMBL   Q5FWJ3_MOUSE UniProtKB/TrEMBL   VIME_MOUSE UniProtKB/Swiss-Prot

More on Vim Entrez Gene Ensembl Gene Genome Browser MGI Report NCBI Map Viewer Vista Vista + UCSC RGD Object Information RGD ID: 733129 Created: 2004-01-12 Species: Mus musculus Last Modified: 2013-04-30 Status: ACTIVE